A股早評:三大指數小幅低開 合成生物、京東金融等板塊盤初活躍
2024年萬億級地方債提前批額度有望本週下達。A股三大指數今日小幅低開,滬指跌0.03%報2917點,深證成指跌0.09%,創業板指跌0.16%。盤面上,合成生物概念股開盤活躍,聖達生物等競價升停;京東金融板塊走高,蔚藍生物競價升停;工程諮詢服務板塊盤初活躍,奧雅股份20cm升停;水產養殖、廣電等板塊升幅居前。另外,培育鑽石板塊走低,亞振家居跌停;草甘膦板塊走弱,潤豐股份低開逾11%;托育服務、eSIM及全息技術等板塊跌幅居前。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.